STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets
STAT
JANUARY 22, 2025
Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Merck’s Keytruda has been used against dozens of different cancers in millions of patients, making it the top-selling drug in the world, with over $25 billion in revenue in 2023.
Let's personalize your content